You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

35 Results
Guidelines and Advice
Status: Archived
ID: 6-18
Version: 2
Jun 2016
Guidelines and Advice
Feb 2016
Drug
Other Name(s): Suprefact® , Suprefact Depot® , Suprefact Nasal Spray®
Nov 2024
Drug
Other Name(s): Avastin® , Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™
Nov 2024
Drug
Other Name(s): Casodex® (multiple brands available)
Apr 2024
Drug
Other Name(s): Velcade®
Nov 2024
Drug
Nov 2024
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Bosulif®
Nov 2024
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Jul 2024
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • buserelin
ODB - General Benefit
  • bicalutamide
Oct 2016
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • bicalutamide
ODB - General Benefit
  • goserelin
Oct 2016

Pages